Safety & Immunogenicity Study of 20vPnC in Healthy Children 15 Months

See also
Status	Clinical Trial	Phase
Completed	`NCT04546425` - 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy Infants	Phase 3
Recruiting	`NCT06044077` - A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People	Phase 3
Completed	`NCT02146365` - Nasopharyngeal Carriage Study in Healthy Kenyan Toddlers
Completed	`NCT04525599` - A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator	Phase 1
Active, not recruiting	`NCT05512819` - A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and Taiwan	Phase 3
Completed	`NCT04530838` - 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants	Phase 3
Active, not recruiting	`NCT06026748` - A Phase I Study of XJ103 in Chinese Healthy Subjects	Phase 1
Completed	`NCT04526574` - Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age	Phase 3
Completed	`NCT05329259` - A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in India	Phase 4
Completed	`NCT00234338` - Study Evaluating Prevenar in High-Risk Children	N/A
Completed	`NCT01767402` - Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults	Phase 1
Active, not recruiting	`NCT05569954` - Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older (V116-010, STRIDE-10)	Phase 3
Completed	`NCT01111214` - Child Pneumococcal Serotype Epidemiology In Greece	N/A
Completed	`NCT01298544` - A Study to Assess the Antibody Response of Healthy Chinese Children Who Have Been Vaccinated Previously With 4-doses of Prevenar (a Pneumococcal Vaccine) as Babies and Toddlers	Phase 4
Completed	`NCT04830358` - Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults	Phase 1
Completed	`NCT04379713` - 20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants	Phase 3
Completed	`NCT04887948` - Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2	Phase 3
Completed	`NCT04382326` - 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants	Phase 3
Not yet recruiting	`NCT00843895` - Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years	N/A
Completed	`NCT01734239` - A Phase III Clinical Trial to Study the Safety and Immunogenicity of Pneumovax™ 23 (V110) in Participants From the Russian Population (V110-018)	Phase 3

NCT number	NCT04642079
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 3
Start date	December 4, 2020
Completion date	April 6, 2022

Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms